Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston
October 31, 2014Orexigen Therapeutics to present Contrave® data at ObesityWeek Meeting November 2-7 in Boston, MA.
More »
Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release Hydrocodone Products
October 31, 2014Zogenix enters an agreement with Purdue Pharma L.P. under which the companies have exchanged waivers of regulatory exclusivity on products. Purdue agrees to pay $10 million and Zogenix may be eligible to receive royalties on Purdue's future sales.
More »
Celator® Pharmaceuticals to Present on Liposome Delivery Systems at 2014 American Association of Pharmaceutical Scientists Annual Meeting
October 30, 2014Celator Pharmaceuticals' president, founder and chief scientific officer, Dr. Lawrence Mayer, will discuss their CombiPlex® platform at the 2014 American Association of Pharmaceutical Scientists Annual Meeting and Exposition in San Diego November 5th.
More »